184 related articles for article (PubMed ID: 6200641)
1. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity.
Tokunaga T; Yamamoto H; Shimada S; Abe H; Fukuda T; Fujisawa Y; Furutani Y; Yano O; Kataoka T; Sudo T
J Natl Cancer Inst; 1984 Apr; 72(4):955-62. PubMed ID: 6200641
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of the DNA fraction from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors.
Shimada S; Yano O; Inoue H; Kuramoto E; Fukuda T; Yamamoto H; Kataoka T; Tokunaga T
J Natl Cancer Inst; 1985 Mar; 74(3):681-8. PubMed ID: 3856070
[TBL] [Abstract][Full Text] [Related]
3. [Commemorative lecture of receiving Imamura Memorial Prize. II. Mode of action of oligonucleotide fraction extracted from Mycobacterium bovis BCG].
Yamamoto S
Kekkaku; 1994 Sep; 69(9):571-4. PubMed ID: 7526022
[TBL] [Abstract][Full Text] [Related]
4. Influence of oil concentration on the efficacy of tumor regression by emulsified components of mycobacteria.
Yarkoni E; Rapp HJ
Cancer Res; 1979 Feb; 39(2 Pt 1):535-7. PubMed ID: 761228
[TBL] [Abstract][Full Text] [Related]
5. Suppression and immunotherapy of the guinea pig line 10 hepatocarcinoma mediated by heat-killed disrupted Mycobacterium bovis strain Bacillus Calmette-Guérin.
Minden P; Mathews HL
Cancer Res; 1980 Sep; 40(9):3214-7. PubMed ID: 6159072
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. I. Synergism between BCG and line 10 tumor cells in the induction of an inflammatory response.
Key ME; Hanna MG
J Natl Cancer Inst; 1981 Oct; 67(4):853-61. PubMed ID: 6944552
[TBL] [Abstract][Full Text] [Related]
7. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
[No Abstract] [Full Text] [Related]
8. Immunotherapy of guinea pigs with a transplanted hepatoma: comparison of intralesionally injected emulsions containing heat-killed Nocardia rubra, Mycobacterium bovis (BCG) and Mycobacterium phlei.
Yarkoni E; Rapp HJ
Oncology; 1982; 39(5):314-8. PubMed ID: 7099513
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapeutic potential in guinea-pig tumor model of deoxyribonucleic acid from Mycobacterium bovis BCG complexed with poly-L-lysine and carboxymethylcellulose.
Kataoka T; Yamamoto S; Yamamoto T; Tokunaga T
Jpn J Med Sci Biol; 1990 Oct; 43(5):171-82. PubMed ID: 1709424
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity on line 10 hepatoma in strain 2 guinea pigs and pharmaceutical properties of quinonyl-MDP preparations.
Azuma I; Ogawa Y; Igari Y; Ukei S; Yamamura Y
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):15-8. PubMed ID: 3702541
[TBL] [Abstract][Full Text] [Related]
11. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
[TBL] [Abstract][Full Text] [Related]
12. [Effects of indomethacin and BCG vaccine on growth of transplanted tumors in mice].
Kurunov IuN; Kaledin VI
Eksp Onkol; 1990; 12(6):57-9. PubMed ID: 2261880
[TBL] [Abstract][Full Text] [Related]
13. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ
Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
[TBL] [Abstract][Full Text] [Related]
14. Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil.
Yarkoni E; Rapp HJ
Cancer Res; 1979 May; 39(5):1518-20. PubMed ID: 427795
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural studies of histiocyte-tumor cell interactions during tumor regression after intralesional injection of Mycobacterium bovis.
Snodgrass MJ; Hanna MG
Cancer Res; 1973 Apr; 33(4):701-16. PubMed ID: 4348772
[No Abstract] [Full Text] [Related]
16. Synergistic activity of components of mycobacteria and mutant Salmonella in causing regression of line-10 tumors in guinea pigs.
McLaughlin CA; Hargrave SL; Bickel WD; Ribi E
Cancer Res; 1979 May; 39(5):1766-71. PubMed ID: 371795
[No Abstract] [Full Text] [Related]
17. Mechanism of action of BCG-tumor cell vaccines in the generation of systemic tumor immunity. II. Influence of the local inflammatory response on immune reactivity.
Key ME; Hanna MG
J Natl Cancer Inst; 1981 Oct; 67(4):863-9. PubMed ID: 6944553
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
de Lisle GW; Wards BJ; Buddle BM; Collins DM
Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
[TBL] [Abstract][Full Text] [Related]
19. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of the guinea pig line 10 hepatocarcinoma with a variety of nonviable bacteria.
Brunda MJ; Mathews HL; Ferguson HR; McClatchy JK; Minden P
Cancer Res; 1980 Sep; 40(9):3211-3. PubMed ID: 6775802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
